Human Physiology I: Nervous and Circulatory Systems
Learning Objectives
By the end of this chapter, you should be able to:
- Describe the organization of the nervous system into central, peripheral, somatic, and autonomic divisions.
- Explain synaptic transmission and identify where common drug classes intervene in the process.
- Describe the blood-brain barrier and explain why it determines which drugs can act on the CNS.
- Explain the components and function of the cardiovascular system relevant to drug distribution.
- Compare sympathetic and parasympathetic effects and connect them to major drug classes.
- Predict how altered circulation (e.g., heart failure) changes drug distribution and dosing.
Quick Answer
The nervous system controls and coordinates the body through electrical and chemical signaling, while the circulatory system delivers everything — oxygen, nutrients, hormones, and drugs — to every cell in the body. Together they explain two of the biggest questions in pharmacology: how does a drug get to its target (circulation), and how does it change behavior, sensation, or organ function once it's there (nervous system)? A drug that can't cross the blood-brain barrier will never act on mood or cognition, no matter how well it's absorbed into the blood. This is why physiology, not just chemistry, decides what a drug can and cannot do.
Core Concepts
Nervous System Organization
Definition: The nervous system is divided into the central nervous system (CNS: brain and spinal cord) and peripheral nervous system (PNS: all nerves outside the CNS). The PNS further splits into the somatic system (voluntary, skeletal muscle control) and autonomic system (involuntary, further divided into sympathetic and parasympathetic divisions).
Explanation: The sympathetic division prepares the body for "fight or flight" (increased heart rate, bronchodilation, pupil dilation) using norepinephrine as its main neurotransmitter, while the parasympathetic division promotes "rest and digest" (decreased heart rate, increased digestion) using acetylcholine. Nearly every autonomic drug class works by mimicking or blocking one of these two systems.
Example: Epinephrine (adrenaline) mimics the sympathetic response — this is exactly why it's used in anaphylaxis, to rapidly counteract airway constriction and low blood pressure by activating the "fight or flight" pathway pharmacologically.
Real-world example: Beta-blockers (like metoprolol) block sympathetic beta-1 receptors on the heart, slowing heart rate and reducing blood pressure — a direct pharmacological override of the sympathetic division, used in hypertension and arrhythmias.
Why it matters: A huge share of cardiovascular, respiratory, and ophthalmic drugs work by tuning the balance between sympathetic and parasympathetic tone. You cannot predict a drug's side-effect profile without knowing which division it shifts.
Common misunderstanding: Students often think "autonomic" means "unimportant" or purely reflexive. In reality, autonomic tone is a major, continuously adjustable therapeutic target — much of cardiology and much of ophthalmology (e.g., glaucoma drops) is autonomic pharmacology.
Synaptic Transmission
Definition: A synapse is the junction where one neuron communicates with another (or with a muscle/gland) via neurotransmitter release. An action potential triggers calcium influx at the presynaptic terminal, causing neurotransmitter-filled vesicles to fuse with the membrane and release their contents into the synaptic cleft.
Explanation: The neurotransmitter diffuses across the cleft and binds receptors on the postsynaptic cell, producing an excitatory or inhibitory effect. The signal is then terminated by reuptake, enzymatic breakdown, or diffusion — and each of these steps is a potential drug target.
Example: Serotonin released at a synapse either gets reabsorbed by the presynaptic neuron (reuptake) or broken down by monoamine oxidase (MAO).
Real-world example: SSRIs (selective serotonin reuptake inhibitors) block the serotonin reuptake transporter, leaving more serotonin in the synaptic cleft for longer — this single mechanistic idea explains both their antidepressant effect and their side effects (GI upset, from serotonin receptors in the gut).
Why it matters: Nearly all CNS and psychiatric drugs act at one of the three points in synaptic transmission: release, receptor binding, or signal termination. Recognizing which point a drug acts on lets you predict its onset, duration, and interactions.
Common misunderstanding: Students often think a neurotransmitter's effect is always the same everywhere in the body. In fact, the same neurotransmitter can produce opposite effects depending on the receptor subtype it binds (e.g., serotonin has at least 14 receptor subtypes with different, sometimes opposing, effects).
The Blood-Brain Barrier
Definition: The blood-brain barrier (BBB) is a selective, semi-permeable boundary formed by tightly joined endothelial cells lining brain capillaries, supported by astrocyte foot processes, that restricts passage of most water-soluble and large molecules from blood into brain tissue.
Explanation: Small, lipophilic (fat-soluble) molecules can cross the BBB by simple diffusion, while large or hydrophilic molecules generally cannot unless actively transported. This barrier protects the brain from toxins and pathogens circulating in the blood, but it also blocks many potentially useful drugs from reaching the CNS.
Example: Diazepam (a benzodiazepine), being highly lipophilic, crosses the BBB rapidly and acts on the CNS within minutes; a large hydrophilic molecule like heparin cannot cross at all.
Real-world example: Levodopa is given (rather than dopamine itself) for Parkinson's disease because dopamine cannot cross the BBB, while levodopa can, and is converted to dopamine once inside the brain — a drug design decision built entirely around BBB physiology.
Why it matters: Whether a drug is designed for CNS effect (must cross the BBB) or deliberately designed to avoid CNS effect (to reduce sedation or other central side effects) depends entirely on this barrier's properties.
Common misunderstanding: Students sometimes think the BBB is a single impermeable wall that blocks everything equally. It's selective, not absolute — lipophilicity, molecular size, and active transport systems all determine what actually crosses, and inflammation (e.g., meningitis) can temporarily increase its permeability.
Cardiovascular System and Drug Distribution
Definition: The circulatory system consists of the heart (pump), blood vessels (arteries, veins, capillaries), and blood (the transport medium). Cardiac output (heart rate × stroke volume) determines how much blood, and therefore how much drug, is delivered per minute.
Explanation: After a drug enters the bloodstream, cardiac output and regional blood flow determine how quickly it reaches different organs. Highly perfused organs (brain, heart, liver, kidney) receive drug quickly; poorly perfused tissues (fat, bone) receive it slowly. Plasma protein binding (mainly to albumin) also affects how much "free" drug is available to leave the blood and act on tissues.
Example: In a well-perfused young healthy adult, an IV drug can reach the brain within one circulation time (about a minute); in a patient with heart failure and reduced cardiac output, the same drug takes longer to reach the same concentration in tissue.
Real-world example: In heart failure, reduced hepatic and renal blood flow slows drug metabolism and excretion, which is exactly why many drug doses (e.g., digoxin) must be adjusted downward in these patients — not because the drug itself changed, but because circulatory physiology changed.
Why it matters: Nearly every pharmacokinetic parameter (onset, distribution, clearance) is downstream of cardiovascular physiology. Disease states that alter cardiac output or blood flow distribution directly change how drugs behave in the body.
Common misunderstanding: Students often think drug distribution is uniform once a drug enters the blood. In reality, distribution is highly dependent on regional blood flow and tissue perfusion, which is why drugs reach the brain and heart long before they reach fat or bone.
Visual Learning: From Drug Administration to CNS Effect
Real-World Applications
Understanding synaptic pharmacology explains why an SSRI takes weeks to show full antidepressant effect even though it blocks reuptake within hours — receptor adaptation downstream of the initial biochemical change takes time. Understanding the BBB explains why a pharmacist counsels a patient that a first-generation antihistamine (which crosses the BBB) causes drowsiness while a second-generation one (which is designed to be a substrate for BBB efflux transporters) does not. And understanding cardiovascular physiology is exactly why critical care pharmacists titrate vasoactive drugs based on real-time cardiac output and blood pressure monitoring, not fixed doses.
Key Terms
| Term | Definition | Why It Matters in Pharmacy |
|---|---|---|
| Sympathetic division | "Fight or flight" branch of the ANS, uses norepinephrine | Target of beta-blockers, epinephrine, decongestants |
| Parasympathetic division | "Rest and digest" branch of the ANS, uses acetylcholine | Target of anticholinergics, cholinesterase inhibitors |
| Synaptic cleft | Gap between presynaptic and postsynaptic neurons | Site of action for reuptake inhibitors and receptor agonists/antagonists |
| Blood-brain barrier (BBB) | Selective barrier restricting substances entering brain tissue | Determines which drugs can produce CNS effects |
| Cardiac output | Volume of blood pumped by the heart per minute (HR × SV) | Determines speed of drug delivery to tissues |
| Plasma protein binding | Reversible binding of drug to proteins like albumin | Only unbound ("free") drug can act on tissues or be eliminated |
| Reuptake | Reabsorption of neurotransmitter by the presynaptic neuron | Blocked by SSRIs, SNRIs, and some stimulants |
| Perfusion | Rate of blood flow to a given tissue | Explains why brain/heart respond to IV drugs faster than fat/bone |
Common Mistakes
Misconception 1: "The sympathetic and parasympathetic systems only matter during stress or extreme situations." Why it's wrong: Both divisions maintain continuous baseline tone in the body, not just during emergencies. Correct understanding: Everyday cardiovascular regulation, pupil size, and digestion are the result of ongoing sympathetic-parasympathetic balance, which is exactly what many chronic medications (beta-blockers, anticholinergics) are designed to shift.
Misconception 2: "The blood-brain barrier blocks all drugs from entering the brain." Why it's wrong: The BBB is selective, not absolute — lipophilic, small molecules cross readily. Correct understanding: CNS-active drugs are specifically designed to be lipophilic enough to cross the BBB; non-CNS drugs are often designed to avoid crossing it to reduce central side effects.
Misconception 3: "Once a drug enters the bloodstream, it reaches all organs at the same time and concentration." Why it's wrong: Distribution depends heavily on regional blood flow (perfusion), not just blood concentration. Correct understanding: Highly perfused organs (brain, heart, kidney, liver) receive drug rapidly, while poorly perfused tissues (fat, bone) receive it much more slowly — this is the basis of multi-compartment pharmacokinetic models.
Comparison and Connections
| Feature | Sympathetic Division | Parasympathetic Division |
|---|---|---|
| Primary neurotransmitter | Norepinephrine | Acetylcholine |
| Effect on heart rate | Increases | Decreases |
| Effect on pupils | Dilates (mydriasis) | Constricts (miosis) |
| Effect on digestion | Inhibits | Stimulates |
| Example drug class | Beta-agonists (albuterol), beta-blockers | Anticholinergics (atropine), cholinesterase inhibitors |
Practice Questions
Recall
- Name the four subdivisions of the nervous system (CNS/PNS and somatic/autonomic) and one function of each. Answer guidance: CNS (brain, spinal cord — processing/integration), PNS (nerves outside CNS — carries signals), somatic (voluntary muscle control), autonomic (involuntary organ control).
- What are the two main structural features that make the blood-brain barrier selective? Answer guidance: Tight junctions between capillary endothelial cells and astrocyte foot processes surrounding the capillaries.
Understanding 3. Explain why levodopa, not dopamine, is used to treat Parkinson's disease. Answer guidance: Dopamine is too hydrophilic/charged to cross the BBB; levodopa is a smaller, transportable precursor that crosses the BBB and is enzymatically converted to dopamine inside the brain. 4. Explain why SSRIs take weeks to produce a full clinical antidepressant effect even though they block serotonin reuptake within hours. Answer guidance: The immediate biochemical effect (more serotonin in the synapse) triggers slower downstream adaptations, such as receptor downregulation and changes in gene expression, which take weeks to produce the full clinical effect.
Application 5. A patient with heart failure and significantly reduced cardiac output is started on a standard dose of an IV antibiotic. What physiological factor should the pharmacist consider regarding onset and clearance? Answer guidance: Reduced cardiac output slows drug delivery to tissues and also reduces hepatic/renal blood flow, potentially slowing metabolism and excretion — dose or interval may need adjustment. 6. A patient in anaphylactic shock is given IM epinephrine. Explain, using autonomic physiology, why this reverses the life-threatening symptoms. Answer guidance: Epinephrine activates sympathetic (adrenergic) receptors, causing bronchodilation (relieves airway constriction) and vasoconstriction (raises blood pressure), directly counteracting the anaphylactic drop in blood pressure and airway narrowing.
Analysis 7. Compare a first-generation antihistamine (e.g., diphenhydramine) and a second-generation antihistamine (e.g., loratadine) in terms of BBB penetration and clinical consequence. Answer guidance: First-generation antihistamines are more lipophilic and cross the BBB readily, causing sedation; second-generation antihistamines are designed to be substrates for BBB efflux transporters (like P-glycoprotein), limiting CNS penetration and reducing sedation. 8. A drug is both highly lipophilic and heavily plasma-protein bound. Analyze how these two properties interact to affect its distribution to the brain. Answer guidance: High lipophilicity favors BBB crossing, but only the unbound (free) fraction of drug is available to cross membranes; if protein binding is very high, the free fraction may be small, meaning distribution to the brain depends on the balance between these two competing properties, not lipophilicity alone.
FAQ
Q: Why is understanding sympathetic vs. parasympathetic balance so important in pharmacy? A: A huge proportion of cardiovascular, respiratory, ophthalmic, and GI drugs work by shifting this balance in one direction or the other — recognizing which side a drug pushes lets you predict both its therapeutic effect and its side effects.
Q: Can any drug be made to cross the blood-brain barrier if scientists want it to? A: Not easily. Increasing lipophilicity or using specific transport systems can help, but this must be balanced against solubility, toxicity, and off-target effects — CNS drug design is one of the harder areas of pharmaceutical development for this reason.
Q: Does plasma protein binding affect how much drug reaches the brain? A: Yes — only unbound drug is pharmacologically active and able to cross membranes like the BBB, so high protein binding can reduce effective brain concentration even for a lipophilic drug.
Q: Why does heart failure require dose adjustments for so many drugs? A: Reduced cardiac output changes both delivery (distribution) and clearance (hepatic/renal blood flow), affecting nearly every pharmacokinetic parameter, not just one.
Q: Is synaptic transmission the same throughout the nervous system? A: The general process (release, receptor binding, termination) is the same, but the neurotransmitter and receptor subtypes vary by location, which is why drugs can be selective for one region or function (e.g., dopamine pathways for movement vs. reward) rather than affecting the whole nervous system uniformly.
Quick Revision
- CNS = brain + spinal cord; PNS = everything else; PNS splits into somatic (voluntary) and autonomic (involuntary).
- Sympathetic = fight or flight, norepinephrine; parasympathetic = rest and digest, acetylcholine.
- Synaptic transmission: release → receptor binding → termination (reuptake or enzymatic breakdown) — each step is a drug target.
- The blood-brain barrier is selective, not absolute — small lipophilic molecules cross; large hydrophilic ones generally do not.
- Levodopa crosses the BBB where dopamine cannot — a classic example of drug design working around physiology.
- Cardiac output (HR × stroke volume) determines the speed of drug delivery to tissues.
- Highly perfused organs (brain, heart, liver, kidney) receive drugs faster than poorly perfused ones (fat, bone).
- Only unbound ("free") drug, not protein-bound drug, can cross membranes or be eliminated.
- Heart failure reduces cardiac output and organ blood flow, changing both drug distribution and clearance.
- First-generation antihistamines cross the BBB and sedate; second-generation ones are designed to avoid it.
Related Topics
Prerequisites: Human Anatomy I (body organization, cavities), Human Anatomy II (skeletal and muscular systems)
Related Topics: Human Physiology II (respiratory, digestive, endocrine systems), Pathophysiology
Next Topics: Human Physiology II — Respiratory, Digestive, and Endocrine Systems; Pathophysiology — Disease Mechanisms